Mention in EMJ Gold June 2020

Mention in EMJ Gold June 2020

Go big or go home, further thoughts on the EMJ Gold mention

I was super honoured to see some of my quotes in the latest GOLD issue.

If you follow me or you hear me speak, I am always anal on the issue of scalability. Call it the entrepreneur in me but the idea of a business that is not scaling is something I can’t compute.

Well it is not working for all ventures obviously. Some businesses will do great at doing few things and doing it really well and I respect that. You have to contextualise my quotes here as I come from a school of thoughts where the brands I work for are

  1. Global
  2. Designed for reaching audiences fast
  3. Tied to a business objectives that is link to a market penetration, customer acquisition or sales directly

The other part is that the projects I work are usually using digital channels for coms and distribution… so you can easily picture that scale mixed with digital channels is something you can easily tie together.

Let’s take an example that will highlight the concept of scalability

If my medical information team is looking to build a qualitative virtual advisory board for 12 people, I would say this is great. I’d start with them, look at these 12 KOLs behaviours and immediately think on how to scale it to 50 countries and 80 brands or 10 therapeutic areas to cover the world…

What I am trying to highlight is that scale should be contextualised according to your total addressable market. Sometimes, in rare diseases, scaling a solution to 200 people is changing the paradigm and this is a great achievement, but then your business case is reflected in the price per treatment.

Enjoy the read, I am here to answer questions or to pursue that conversation. Prove me wrong as well I love a debate.

Stay safe

Haider

Related Articles

Responses

Your email address will not be published. Required fields are marked *

Sign-up for my newsletter

Hacking Health Camp 2020

NextPharma Dubrovnik 2020

EyeforPharma Tokyo 2020

EyeforPharma Tokyo 2020